-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 2, Yiling Pharmaceutical issued an announcement and received a notice of drug clinical trial approval for Xiaoerlianhua Qinggan Granules approved and issued by the National Medical Products Administration.
It is reported that the drug is a traditional Chinese medicine compound preparation, which is intended to be used for 4-12 year old children with cold wind-heat invasion of lung health syndrome